Francisco das Chagas Alves Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francisco das Chagas Alves Lima has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Janilson L. Souza
Federal Institute of Education, Science and Technology of Maranhão, IFMA, Bacabal, Maranhão, Brazil
2 shared publicationsRayla K. M. Costa
Research Laboratory of the Computational Quantum Chemistry and Drug Planning Group, Chemistry Department, State University of Piauí, GQQC&PF/UESPI, Teresina, Piauí, Brazil
2 shared publicationsRicardo M. Ramos
Research Laboratory in Information Systems, Information Department, Environment, Health and Food Production, Federal Institute of Education, Science and Technology of Piauí, LaPeSI/IFPI, Teresina, Piauí, Brazil
2 shared publicationsÉzio R. A. de Sá
Federal Institute of Education, Science and Technology of Piauí, IFPI, Picos, Piauí, Brazil
2 shared publications- Aldenora Maria Ximenes Rodrigues
Núcleo de Tecnologias Estratégicas em Saúde – Universidade Estadual da Paraíba – Campina Grande – Paraíba – Brasil
1 shared publication Allan N. Costa
Federal Institute of Education, Science and Technology of Pará, IFPA, Conceição do Araguaia, Brazil
1 shared publication
Latest Publications
- Open Access
- 2 February 2026
- Published by Editoriales Iberoamericanos in Revista DCS
- Vol. 23 (87) , e4445
IN SILICO STUDY OF FARNESOL AND ITS USE IN EMULSION AS A POTENTIAL TREATMENT FOR GASTRIC ULCER
Farnesol is an organic component found in various natural essential oils with antioxidant, antimicrobial, and antidiarrheal properties. It emerges as an alternative in treating inflammatory diseases such as gastric ulcers, characterized by an imbalance between protective components and aggressive factors affecting the entire gastrointestinal tissue. Conventional medications, although practical, cause adverse effects such as rebound and increased risk of gastric cancer, underscoring the need to develop safer alternative and natural treatments. This study aimed to conduct in silico studies of Farnesol and develop an emulsion containing farnesol targeted at gastroprotective activity in a standardized gastric ulcer induction model. The in silico study investigated the therapeutic action of Farnesol in the treatment of gastric ulcers through molecular docking with specific targets. Our analyses indicated interactions with the COX-2 enzyme, suggesting possible inhibition of this enzyme by Farnesol. We also observed interactions with the M³ muscarinic receptor, TNF-α, and TGF-β. We developed an emulsion containing Farnesol, which exhibited satisfactory physicochemical characteristics with a pH of 6.13 and conductivity of 13.29 µS/cm, enhancing emulsion stability and reducing the risk of phase separation. The average zeta potential was -38.9 mV, and the average particle size of the emulsion was 1133 nm, reducing the likelihood of aggregation and increasing emulsion stability. The in vivo study was conducted with experiments on mice with gastric ulcer induction using an experimental model that employs ethanol as an aggressive agent. The results showed a reduction in lesion size of 43.8%, 42%, and 74.38% at the tested doses of 25, 50, and 100 mg/kg, respectively. The research utilized a descriptive methodology. We suggest that Farnesol may present significant anti-inflammatory potential, and we found, through a standardized model, that the emulsion constitutes a therapeutic option for protecting the gastric mucosa.
- 2 February 2026
- Published by Editoriales Iberoamericanos in Revista DCS
- Vol. 23 (87) , e4445
Open AccessIN SILICO STUDY OF FARNESOL AND ITS USE IN EMULSION AS A POTENTIAL TREATMENT FOR GASTRIC ULCER
Farnesol is an organic component found in various natural essential oils with antioxidant, antimicrobial, and antidiarrheal properties. It emerges as an alternative in treating inflammatory diseases such as gastric ulcers, characterized by an imbalance between protective components and aggressive factors affecting the entire gastrointestinal tissue. Conventional medications, although practical, cause adverse effects such as rebound and increased risk of gastric cancer, underscoring the need to develop safer alternative and natural treatments. This study aimed to conduct in silico studies of Farnesol and develop an emulsion containing farnesol targeted at gastroprotective activity in a standardized gastric ulcer induction model. The in silico study investigated the therapeutic action of Farnesol in the treatment of gastric ulcers through molecular docking with specific targets. Our analyses indicated interactions with the COX-2 enzyme, suggesting possible inhibition of this enzyme by Farnesol. We also observed interactions with the M³ muscarinic receptor, TNF-α, and TGF-β. We developed an emulsion containing Farnesol, which exhibited satisfactory physicochemical characteristics with a pH of 6.13 and conductivity of 13.29 µS/cm, enhancing emulsion stability and reducing the risk of phase separation. The average zeta potential was -38.9 mV, and the average particle size of the emulsion was 1133 nm, reducing the likelihood of aggregation and increasing emulsion stability. The in vivo study was conducted with experiments on mice with gastric ulcer induction using an experimental model that employs ethanol as an aggressive agent. The results showed a reduction in lesion size of 43.8%, 42%, and 74.38% at the tested doses of 25, 50, and 100 mg/kg, respectively. The research utilized a descriptive methodology. We suggest that Farnesol may present significant anti-inflammatory potential, and we found, through a standardized model, that the emulsion constitutes a therapeutic option for protecting the gastric mucosa.
- Open Access
- 1 January 2025
- Published by Even3
- Vol. 9, 1
Métodos in silico para detecção de novas substâncias psicoativas no âmbito forense
A Pós-graduação como Estratégia de Desenvolvimento Sustentável na Amazônia Legal (978-65-272-1477-9) - Métodos In Silico Para Detecção De Novas Substâncias Psicoativas No Âmbito Forense
- 1 January 2025
- Published by Even3
- Vol. 9, 1
Open AccessMétodos in silico para detecção de novas substâncias psicoativas no âmbito forense
A Pós-graduação como Estratégia de Desenvolvimento Sustentável na Amazônia Legal (978-65-272-1477-9) - Métodos In Silico Para Detecção De Novas Substâncias Psicoativas No Âmbito Forense
- Open Access
- 2 September 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (9) , e7430
Brain tumor classification model using convolutional neural networks on magnetic resonance imaging
Accurate classification of brain tumor images is an important challenge in the field of healthcare, demanding fast and reliable diagnoses for proper treatment. In this article, we propose a model that enhances for the automated classification of brain tumor images brain tumor classification, aiming to support diagnostics, increase confidence, and reduce time in the classification process of meningioma, glioma, and pituitary tumors, in magnetic resonance imaging (MRI) scans. Our results demonstrated that the VGG16 model achieved the best classification results among the three evaluated models. Its deep architecture and learning capacity allowed it to learn more discriminative representations of brain tumors, resulting in a higher accuracy rate. Furthermore, the results of the VGG16 implementation were compared to previous studies representing the state of the art in the field. This comparison highlighted the effectiveness and relevance of the VGG16 model for this classification problem. These results offer valuable insights for future development of automated brain tumor detection systems.
- 2 September 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (9) , e7430
Open AccessBrain tumor classification model using convolutional neural networks on magnetic resonance imaging
Accurate classification of brain tumor images is an important challenge in the field of healthcare, demanding fast and reliable diagnoses for proper treatment. In this article, we propose a model that enhances for the automated classification of brain tumor images brain tumor classification, aiming to support diagnostics, increase confidence, and reduce time in the classification process of meningioma, glioma, and pituitary tumors, in magnetic resonance imaging (MRI) scans. Our results demonstrated that the VGG16 model achieved the best classification results among the three evaluated models. Its deep architecture and learning capacity allowed it to learn more discriminative representations of brain tumors, resulting in a higher accuracy rate. Furthermore, the results of the VGG16 implementation were compared to previous studies representing the state of the art in the field. This comparison highlighted the effectiveness and relevance of the VGG16 model for this classification problem. These results offer valuable insights for future development of automated brain tumor detection systems.
- Open Access
- 7 May 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Computational simulations of Ru(II) complexes with coordinated jaborandi ligands and their potential for interaction with Trypanosoma cruzi proteases
Chagas disease is a parasitic infection caused by the protozoan Trypanosoma cruzi, in which conventional treatment is based on medications such as benznidazole and nifurtimox, which have limitations, such as side effects and parasitic resistance. Thus, some metallopharmaceuticals have been studied as potential therapeutic agents, in this sense, the present in silico study predicts the interaction capacity of Ru(II) complexes formed with jaborandi alkaloid ligands, against the protozoan sterol 14α-demethylase and cruzain proteases. The physicochemical properties, ADME-Tox, druglikeness and biological activity of the in silico complexes, predicted from website databases, were also evaluated. The complexes with the best binding affinities after molecular docking were those with the target cruzain, with emphasis on [RuNO(bipy)2IPS]3+, [RuCl(bipy)2PS]+, [RuNO(bipy)2PS]3 + and [RuCl(bipy)2IPS]+, carrying out important chemical interactions with the amino acid residues Cys25, Gln19, Gly66, Gly23 and Trp26. Only [RuCl(bipy)2PS]+, [RuCl(bipy)2IPS]+ and [RuCl(bipy)2EPS]+ showed activities for antiprotozoal (Trypanosoma), anticarcinogenic and antitoxic actions. The complexes under study have good oral bioavailability, lipophilicity, aqueous solubility, permeability, absorption and absence of neurotoxicity. However, the proposed compounds still need to undergo in vitro and in vivo laboratory tests to carry out new studies.
- 7 May 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessComputational simulations of Ru(II) complexes with coordinated jaborandi ligands and their potential for interaction with Trypanosoma cruzi proteases
Chagas disease is a parasitic infection caused by the protozoan Trypanosoma cruzi, in which conventional treatment is based on medications such as benznidazole and nifurtimox, which have limitations, such as side effects and parasitic resistance. Thus, some metallopharmaceuticals have been studied as potential therapeutic agents, in this sense, the present in silico study predicts the interaction capacity of Ru(II) complexes formed with jaborandi alkaloid ligands, against the protozoan sterol 14α-demethylase and cruzain proteases. The physicochemical properties, ADME-Tox, druglikeness and biological activity of the in silico complexes, predicted from website databases, were also evaluated. The complexes with the best binding affinities after molecular docking were those with the target cruzain, with emphasis on [RuNO(bipy)2IPS]3+, [RuCl(bipy)2PS]+, [RuNO(bipy)2PS]3 + and [RuCl(bipy)2IPS]+, carrying out important chemical interactions with the amino acid residues Cys25, Gln19, Gly66, Gly23 and Trp26. Only [RuCl(bipy)2PS]+, [RuCl(bipy)2IPS]+ and [RuCl(bipy)2EPS]+ showed activities for antiprotozoal (Trypanosoma), anticarcinogenic and antitoxic actions. The complexes under study have good oral bioavailability, lipophilicity, aqueous solubility, permeability, absorption and absence of neurotoxicity. However, the proposed compounds still need to undergo in vitro and in vivo laboratory tests to carry out new studies.
- 8 February 2022
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (6) , 2555-2573
Computational investigation of the alkaloids of Pilocarpus microphyllus species as phytopharmaceuticals for the inhibition of sterol 14α-demethylase protease of Trypanosoma cruzi
Trypanosoma cruzi is a protozoan transmitted by the insect Triatoma infestans, popularly known as kissing bug. This protozoan causes the Chagas disease, a Neglected Tropical Disease. This study aimed to investigate, through DFT method and B3LYP hybrid functional, the physicochemical, pharmacokinetic, and pharmacodynamic properties of the alkaloids present in the leaves of the species Pilocarpus microphyllus (jaborandi) as a potential inhibitory activity on the protease sterol 14α-demethylase of T. cruzi associated with the techniques of molecular docking, molecular dynamics, MM-PBSA and ADMET predictions. The molecules of isopilosine, epiisopiloturine, epiisopilosine, and pilosine showed up the lowest binding energies by molecular docking, good human intestinal absorption, low penetration in the blood-brain barrier, antiprotozoal and anticarcinogenic activities in ADMET studies. It has been observed a better binding affinity of the sterol 14α-demethylase protease with isopilosine in molecular dynamics and MM-PBSA studies, which indicates it as a potential drug candidate for Chagas disease. Communicated by Ramaswamy H. Sarma
- 8 February 2022
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (6) , 2555-2573
Computational investigation of the alkaloids of Pilocarpus microphyllus species as phytopharmaceuticals for the inhibition of sterol 14α-demethylase protease of Trypanosoma cruzi
Trypanosoma cruzi is a protozoan transmitted by the insect Triatoma infestans, popularly known as kissing bug. This protozoan causes the Chagas disease, a Neglected Tropical Disease. This study aimed to investigate, through DFT method and B3LYP hybrid functional, the physicochemical, pharmacokinetic, and pharmacodynamic properties of the alkaloids present in the leaves of the species Pilocarpus microphyllus (jaborandi) as a potential inhibitory activity on the protease sterol 14α-demethylase of T. cruzi associated with the techniques of molecular docking, molecular dynamics, MM-PBSA and ADMET predictions. The molecules of isopilosine, epiisopiloturine, epiisopilosine, and pilosine showed up the lowest binding energies by molecular docking, good human intestinal absorption, low penetration in the blood-brain barrier, antiprotozoal and anticarcinogenic activities in ADMET studies. It has been observed a better binding affinity of the sterol 14α-demethylase protease with isopilosine in molecular dynamics and MM-PBSA studies, which indicates it as a potential drug candidate for Chagas disease. Communicated by Ramaswamy H. Sarma
- 2 January 2021
- Published by Taylor & Francis in Molecular Simulation
- Vol. 47 (1) , 74-87
In silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS-CoV-2
The disease outbreak caused by SARS-CoV-2 continues to rise worldwide, even in countries which have considered it controlled. As new cases appear daily, infecting millions of people and causing thousands of deaths, the current in silico study aims to investigate the imidazolic alkaloids of the species Pilocarpus microphyllus (Jaborandi) as a potential inhibitory activity against the Mpro protease from SARS-CoV-2, since it plays a fundamental role in the processing of polyproteins that are translated from viral RNA. Jaborandi is distributed in some Brazilian biomes, being easily identified, yet little researched, with proven anti-inflammatory, contraceptive, anti-diabetic and gastroprotective activities. In this work, DFT calculation of thermodynamic properties, electrostatic potential surface, frontier molecular orbitals and descriptors of chemical reactivity of imidazolic alkaloids were associated with the use of molecular docking techniques, molecular dynamics and ADMET predictions. One can verify a good reactivity chemistry and energetic stability of epiisopiloturine, epiisopilosine, isopilosine and e pilosine with some residues of amino acids present in the active site of the main protease of COVID-19. In this sense, the results point out to the imidazolic alkaloids of Jaborandi as promising targets for in vitro and in vivo tests, as possible candidates for inhibitors of the enzyme Mpro.
- 2 January 2021
- Published by Taylor & Francis in Molecular Simulation
- Vol. 47 (1) , 74-87
In silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS-CoV-2
The disease outbreak caused by SARS-CoV-2 continues to rise worldwide, even in countries which have considered it controlled. As new cases appear daily, infecting millions of people and causing thousands of deaths, the current in silico study aims to investigate the imidazolic alkaloids of the species Pilocarpus microphyllus (Jaborandi) as a potential inhibitory activity against the Mpro protease from SARS-CoV-2, since it plays a fundamental role in the processing of polyproteins that are translated from viral RNA. Jaborandi is distributed in some Brazilian biomes, being easily identified, yet little researched, with proven anti-inflammatory, contraceptive, anti-diabetic and gastroprotective activities. In this work, DFT calculation of thermodynamic properties, electrostatic potential surface, frontier molecular orbitals and descriptors of chemical reactivity of imidazolic alkaloids were associated with the use of molecular docking techniques, molecular dynamics and ADMET predictions. One can verify a good reactivity chemistry and energetic stability of epiisopiloturine, epiisopilosine, isopilosine and e pilosine with some residues of amino acids present in the active site of the main protease of COVID-19. In this sense, the results point out to the imidazolic alkaloids of Jaborandi as promising targets for in vitro and in vivo tests, as possible candidates for inhibitors of the enzyme Mpro.